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Disabled-2 (Dab2) is a clathrin and cargo binding endocytic adaptor protein, and cell
biology studies revealed that Dab2 plays a role in cellular trafficking of a number
of transmembrane receptors and signaling proteins. A PTB/PID domain located in
the N-terminus of Dab2 binds the NPXY motif(s) present at the cytoplasmic tails
of certain transmembrane proteins/receptors. The membrane receptors reported to
bind directly to Dab2 include LDL receptor and its family members LRP1 and LRP2
(megalin), growth factor receptors EGFR and FGFR, and the cell adhesion receptor
beta1 integrin. Dab2 also serves as an adaptor in signaling pathways. Particularly, Dab2
facilitates the endocytosis of the Ras activating Grb2/Sos1 signaling complex, controls its
disassembly, and thereby regulates the Ras/MAPK signaling pathway. Cellular analyses
have suggested several diverse functions for the widely expressed proteins, and Dab2
is also considered a tumor suppressor, as loss or reduced expression is found in several
cancer types. Dab2 null mutant mice were generated and investigated to determine if
the findings from cellular studies might be important and relevant in intact animals. Dab2
conditional knockout mice mediated through a Sox2-Cre transgene have no obvious
developmental defects and have a normal life span despite that the Dab2 protein is
essentially absent in the mutant mice. The conditional knockout mice were grossly
normal, though more recent investigation of the Dab2-deficient mice revealed several
phenotypes, which can be accounted for by several previously suggested mechanisms.
The studies of mutant mice established that Dab2 plays multiple physiological roles
through its endocytic functions and modulation of signal pathways.
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INTRODUCTION
Disabled 2 (Dab2) is an endocytic adaptor: Dab2 may impact the uptake of certain extracellular
proteins or molecules and may also influence cellular signaling by trafficking components in the
pathways. A large number of cellular functions have been proposed for Dab2 and studied in cell
culture systems. Although, Dab2 constitutive knockout mice are early embryonic lethal, cre-lox
Abbreviations: AP2, Adaptin protein 2; aP2, adipocyte protein 2; Dab2, Disabled 2; EGF, Epidermal Growth Factor;
HMG-CoA, 3-hydroxy-3-methyl-glutaryl-coenzyme A; LDL, low density lipoprotein; LRP, low density lipoprotein-related
protein; PRD, proline-rich domain; PTB/PID, PhosphoTyrosine Binding, or Phosphotyrosine Interacting Domain; TGF-beta,
transforming growth factor beta; Treg, regulatory T cell.
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approach enables the study of its functions in physiology.
Particularly, Dab2 null mice can be produced by mosaic deletion
using Sox2-Cre. Characterization of Dab2 null mice revealed
several phenotypes, both expected and surprised, and verified the
links between cellular functions in endocytosis and signaling to
the identified physiological functions (Table 1).
DAB2 IDENTIFICATION AND A BRIEF
HISTORY
Disabled-2 (Dab2), a mammalian ortholog of Drosophila
Disabled (Gertler et al., 1989), was first isolated from a murine
macrophage cell line as a phospho-protein, p96, involved in CSF-
1 signal transduction (Xu et al., 1995). The first report of Dab2
in the literature was a short fragment of mRNA identified in
differential screening, known as DOC-2 (differentially expressed
in ovarian cancer; Mok et al., 1994). At a later time, another Dab2
cDNA was also isolated as a gene induced by castration in rodent
models, named as C9 (Tseng et al., 1998).
Sequence alignment indicated that mammalian Dab2 and a
neuron specific isoform Dab1 are orthologs of the Drosophila
Disabled gene, which was suggested to play a role in neuron
development in fly. In mammals, Dab2 is widely expressed (Xu
et al., 1998; Fazili et al., 1999), but Dab1 is restricted to brain
(Howell et al., 1997; Sheldon et al., 1997). Several spliced isoforms
including p96, p93, and p67 were identified as the protein
products of the Dab2 gene (Xu et al., 1995; Sheng et al., 2000a,
2001).
Among the protein sequences included in the NBCI
database (https://www.ncbi.nlm.nih.gov/protein/?term=Dab2),
mammalian Dab2 is most similar to Dab1, Numb, Numbl, and
Arh, which are all endocytic adaptor proteins. The homology
is highest at the C-terminus, defined by a domain known as
PTB/PID (Phospho-Tyrosine Binding or Phosphotyrosine
Interacting Domain) domain (Bork and Margolis, 1995).
Dab2 is essential for mouse embryonic development and gene
deletion in mice causes early embryonic lethality at a stage
prior to gastrulation (Morris et al., 2002b; Yang et al., 2002a,
2007). The embryonic phenotype of the mutant mice indicates
that Dab2 is critical in the development of extra-embryonic
endoderm. In the dab2-deficient embryos, extra-embryonic
endoderm cells are present but fail to sort and form primitive
TABLE 1 | Phenotypes of Dab2 mutant mice.
Tissues/cell types Phenotypes References
Blastocysts/primitive and extraembryonic endoderm
early embryos
Failed cell sorting Morris et al., 2002b; Yang et al., 2002b, 2007;
Moore et al., 2013
Kidney/proximal convoluted tubule epithelia Mild proteinuria Morris et al., 2002b; Moore et al., 2013
Mammary glands/epithelia Delayed involution Tao et al., 2014
Liver/sinusoidal endothelial cells Increased serum cholesterol Moore et al., 2013; Tao et al., 2016a
Adipose/Adipocytes/pericytes Resistant to induced adipogenesis Tao et al., 2016b
Immune system/Treg No obvious phenotype in vivo; failed to suppress T cells Jain et al., 2009
Tumors/multiple types Uterine hyperproliferation, Ovarian epithelial growth, Increased
tumor incidence
Yang et al., 2006; Moore et al., 2013
and subsequent visceral endoderm epithelia. Rather, the extra-
embryonic endoderm cells intermingle with the ectoderm cells
(Yang et al., 2002a, 2007, 2009; Moore et al., 2013). Analyses in
embryoid bodies and cultured cells support that Dab2 is critical
for the surface targeting and restriction of cell adhesionmolecules
and the establishment and maintenance of epithelial polarity
(Rula et al., 2007; Moore et al., 2013). Therefore, Dab2 functions
in endocytic trafficking to sustain cell polarity and thus epithelial
organization, and hence loss of Dab2 leads to endoderm epithelial
disorganization and failure of the embryos (Rula et al., 2007; Yang
et al., 2007; Moore et al., 2013).
DAB2 AS AN ENDOCYTOSIS ADAPTOR
The domains and sequence motifs indicate that Dab2 is an
endocytic adaptor protein (Mishra et al., 2002; Bonifacino and
Traub, 2003; Hasson, 2003; Figure 1). At the N-terminus, Dab2
possesses a PTB/PID domain that can bind an NPXY (Asn-Pro-
X-Tyr, X represents any amino acid) motif found in a subset
of cell surface receptors (Bork and Margolis, 1995). Through its
PTB domain, Dab2mediates the attachment of cargos containing
transmembrane proteins with an NPXY motif, such as the LDL
receptor, EGF receptor, megalin, and integrins, to clathrin coats
(through DFF motifs; Mishra et al., 2002; Morris et al., 2002a;
Bonifacino and Traub, 2003; Hasson, 2003). Dab2 proteins also
contain clathrin binding, NPF, and DPF motifs, which bind
components of endocytic vesicles such as clathrin, alpha-adaptin,
and EPS-15, respectively (Traub, 2003). The C-terminus binds
to the myosin VI motor protein (Inoue et al., 2002; Morris
et al., 2002a; Hasson, 2003; Spudich et al., 2007). Thus, Dab2
links clathrin-coated cargos containing transmembrane proteins
with an NPXY motif to the myosin motor, facilitating their
endocytosis and directional trafficking (Morris et al., 2002a;
Hasson, 2003). Studies in cultured cells suggested a role of
Dab2 in endocytic recycling and trafficking of integrins and
thus impact cell mobility (Caswell et al., 2009; Chao and Kunz,
2009; Chetrit et al., 2009; Teckchandani et al., 2009). Also,
participation in the clathrin-mediated endocytosis and trafficking
of E-cadherin explains its affects on epithelial organization (Yang
et al., 2007). Thus, its functions in mediating polarized trafficking
of cell adhesion molecules such as integrins and E-cadherin
provide possible mechanisms for failure in endoderm epithelial
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FIGURE 1 | Structure of Dab2 adaptor and a working model of its function in endocytosis and signaling. Dab2 has two main spliced forms, p96 and p67.
The N-terminal PID/PTB domain of Dab2 binds to the NPXY motif in the intracellular domain of transmembrane glycoproteins/receptors such as LDL receptor, LRP
family members, and integrins. The middle and C-terminal portions of Dab2 interact with endocytosis proteins clathrin and alpha-adaptin. The C-terminal portion of
the protein also can bind myosin VI, a motor protein that mediates endocytic trafficking. Thus, Dab2 links endocytic vesicles to myosin VI motor trafficking along
cellular actin filaments, targeting membrane proteins on the cargos to unique cell surface domains. Dab2 also has a proline-rich domain (PRD) that can bind
SH3-containing proteins such as Grb2, Fyn, and Src. Dab2 protein is most similar to other adaptor proteins including neuronal specific family member Dab1, Numb,
Numbl, and Arh. The amino acid (aa) numbers are indicated for either mouse (m) or human (h) proteins.
polarity, sorting, and organization of Dab2 deleted embryos
(Yang et al., 2007; Moore et al., 2013).
In addition, Dab2 has feature of an signaling adaptor, as the C-
terminal part of the protein contains a proline-rich domain that
mediates the association of Dab2 with additional proteins, such as
Grb2, Src, and Fyn (Xu et al., 1998; Figure 1). Thus, a scenario is
presented that Dab2 also mediates the endocytosis and trafficking
of components of various signaling pathways. By doing so, Dab2
acts to modulate cellular signalings. Indeed, endocytosis and
trafficking of cell surface receptors and signaling components
have been suggested to account for its activities in modulating
multiple cellular signaling pathways, including Ras/MAPK (Xu
et al., 1998; He et al., 2001; Zhou and Hsieh, 2001), TGF-beta
(Hocevar et al., 2001, 2005; Prunier and Howe, 2005; Hannigan
et al., 2010), and Wnt (Hocevar et al., 2003; Jiang et al., 2008,
2009, 2012).
The Dab2 protein domains and structure are similar to a
family member Dab1 in mammals, though Dab1 is mainly
expressed in brain and neuronal cells (Howell et al., 1997). No
redundancy between Dab1 and Dab2 activity has been found or
reported, likely because of their divergent tissue expression. Dab2
protein sequences are also similar to other signal or endocytosis
adaptor proteins including numb, numbl, and Arh protein
(Figure 1). Compensatory expression and partial functional
redundancy by numb andArh have been noted in Dab2 knockout
mice (Moore et al., 2013; Tao et al., 2014, 2016a).
DAB2 IN THE REGULATION OF CELLULAR
SIGNALING PATHWAYS
In cell culture studies, Dab2 also was shown to modulate several
signaling pathways. It was reported that Dab2 serves as an
adaptor linking the transforming growth factor beta (TGF-beta)
receptors with the Smad family proteins, facilitating TGF-beta
signal transduction pathway (Hocevar et al., 2001). Another
study indicates that Dab2 facilitates the cellular endocytosis
and trafficking of TGF-beta receptor (Penheiter et al., 2010).
Additional studies suggested detailed mechanisms for the
participation of Dab2 in regulating the TGF-beta pathway
(Hocevar et al., 2005; Prunier and Howe, 2005; Chaudhury
et al., 2010). In contrast, another study found that Dab2 dose
not impact the canonical TGF-beta pathway but Dab2 loss
in head and neck cancer compromised the tumor suppressor
function of TGF-beta, while enabling its tumor-promoting
activities, and concluded that Dab2 is a molecular switch for
TGF-beta from a tumor suppressor to a promoter (Hannigan
et al., 2010). Thus, several mechanisms have been suggested
for the involvement of Dab2 in TGF-beta pathway, such
as receptor recycling, adapting function for Smad activation,
or non-canonical TGF-beta signaling through the Ras-MAPK
pathway, although the actual operation of these mechanisms
in intact animals and physiological settings have yet to be
demonstrated.
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Through its functions in endocytosis of signaling components
such as Axin or LRP6, Dab2 is also suggested to plays
roles in the regulation of the Wnt pathways (Hocevar et al.,
2003; Jiang et al., 2008, 2009, 2012). Deletion of Dab2
in zebrafish embryos through Cas9 mutagenesis resulted in
a significant reduction in cardiomyocyte number (Hofsteen
et al., 2016), though impact of Dab2 deletion on cardiac
development is not notable (Morris et al., 2002b; Moore et al.,
2013).
The Dab2 proline-rich domain (PRD) at C-terminus contains
multiple stretches of poly-proline motifs that resemble those in
Sos1, a guanine nucleotide exchange factor for and activator
of Ras (Xu et al., 1998; Figure 1). Through the PRD, Sos1
binds strongly to the two SH3 domains of the signaling adaptor
Grb2, which associates with phosphorylated and activated
transmembrane signaling receptors through the SH2 domain
of Grb2. Thus, Grb2 recruits Sos1 to membrane receptors to
mediate Ras activation (McCormick, 1993). Since the two SH3
domains of Grb2 bind competitively to both Sos1 and Dab2, to
their proline-rich motifs, expression levels and phosphorylation
of Dab2 and Sos1 modulate the abundance of Sos1/Grb2
complexes. By competing with Sos1 for binding to Grb2,
Dab2 acts as a negative regulator for Ras/MAPK pathway (Xu
et al., 1998; Zhou and Hsieh, 2001). In cultured cells, Dab2
modulates endosomal Ras/MAPK (Erk1/2) activity by regulating
the disassembly of Grb2/Sos1 complexes associated with clathrin-
coated vesicles (Xu et al., 1998; Fehrenbacher et al., 2009;
Smith et al., submitted). Additionally, a suppressive activity
of Dab2 was observed on the MAPK downstream effector,
the expression of c-Fos (He et al., 2001; Smith et al., 2001;
Yang et al., 2009). The model suggests a role for Dab2 in
mediating the endocytosis of signaling complexes and regulating
signaling at the endosomes (Figure 2; Vieira et al., 1996).
Several events are speculated (Buday et al., 1995; Vieira et al.,
1996; Smith et al., submitted): (1) growth factor binds to its
tyrosine kinase receptor, which autophosphorylates and recruits
Grb2/Sos1 complexes; (2) at the plasma membrane, the activated
receptor and signaling complexes initiate the first phase of
Ras/MAPK signaling; (3) alpha-adaptin and additional endocytic
adaptors such as Dab2 mediate assembly of clathrin-coated pits
and the formation of endosomes; 4) the endosome undergoes
disassembly of adaptin and clathrin coating, and at the same
time, the cargo proteins undergo phosphorylation-triggered
rearrangement.
Among the Dab2-associated cellular signaling pathways
suggested from cell culture studies, an increase in total
Erk1/2 activity was observed in the total embryonic lysate of
E9.5 Dab2 null embryos (Smith et al., submitted), suggesting
Dab2 has a physiological role in the fine-tuning of the
Ras/MAPK pathway. Indeed, a role of Dab2 in suppressing
Ras/MAPK activation accounts for embryonic development
(Yang et al., 2009) and several physiological phenotypes observed
in Dab2 null mice (Tao et al., 2014, 2016b). Probably, the
activity as a negative regulator of the Ras/MAPK pathway
contributes to the tumor suppressor activity of Dab2 as
well.
FIGURE 2 | Dab2 modulation of Ras/MAPK pathway at the endosomal
membranes, and Dab2 function in a feedback mechanism of the
Ras/MAPK pathway. Receptor tyrosine kinases (RTK), including EGF and
TGF-beta receptors, signal through the Grb2-Sos1 complexes and their
activation of Ras, and downstream cascade Raf, MEK, and Erk1/2 to regulate
cell proliferation, motility, and differentiation. Grb2 interacts through its SH2
domain binding to phosphotyrosine residue of the activated RTK, and binds
via its SH3 domains to the proline-rich domain of Sos1 or Dab2.
Phosphorylation of Sos1 and Dab2 by Erk1/2 leads to disassociation of
Sos1/2 from Grb2, which is then sequestered by Dab2. The disassembly of
Sos1/Grb2 complexes leads to the termination of Ras activation, serving as a
feedback regulatory loop in the control of the Ras/MAPK pathway. The
re-arrangement of Grb2/Sos1 complex to Grb2/Dab2 association likely
coincides with clathrin and adaptor coat disassembly. Loss of Dab2 in cancer
cells leads to unsuppressed Ras/MAPK activation.
DAB2 EXPRESSION AND TISSUE
DISTRIBUTION
Full length Dab2 cDNAs were first isolated from a mouse
macrophage cell line (Xu et al., 1995), and a fragment was also
identified in another study as a gene that is expressed in human
ovarian surface epithelial cells but lost in ovarian carcinomas
(Mok et al., 1994). In initial tissue profiling, Dab2 was found
widely expressed (Fazili et al., 1999), in contrast to the brain and
neuronal specific isoform, Dab1 (Howell et al., 1997).
Using the public GeneAtlas dataset, Dab2 expression is
profiled in both mouse (Figure 3A) and human (Figure 3B)
tissues. In, Dab2 is seen highly expressed in extraembryonic
tissues (placenta) during development. In adults, Dab2 mRNA
is present in most tissues at a low level, but is noticeably higher
in macrophages, kidney, white adipose tissues, adrenal, and
lactating mammary glands (Figure 3). As expected, physiological
phenotypes in the Dab2 conditional knockout mice have been
observed in many of these tissues or cell types that have high
Dab2 expression in wild-type mice (below).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 4 November 2016 | Volume 4 | Article 129
Tao et al. Phenotypes of Dab2 Null Mice
FIGURE 3 | Expression spectrum of Dab2 mRNA in murine and human tissues. (A) Dab2 expression in mouse tissues. Microarray data sets were acquired
from an online public dataset GeneAtlas MOE430, gcrma (http://biogps.org/#goto=genereport&id=13132). The high-throughput gene expression profiling for Dab2
was generated from a diverse array of normal tissues, organs, and cell lines from mice. The final readouts were averages of four different probe sets with standard
error of the mean (SEM) shown as error bars, normalized to housekeeping genes, and ranked according to the abundance of mRNA expression. (B) Dab2 expression
in human tissues. Similar approaches were used to show Dab2 expression in human tissues.
FUNCTION IN LDL UPTAKE AND
CHOLESTEROL HOMEOSTASIS
The members of the LDL (low density lipoprotein) receptor
family contain the NPXY motif(s) specifically recognized by
Dab2 (Willnow et al., 1999; Herz et al., 2000; Hussain, 2001;
Stolt and Bock, 2006), and thus a role in LDL uptake and
cholesterol metabolism is anticipated. In studies using cultured
cells, Dab2 was found to play a role in the endocytosis of
LDL receptor, in coordination with Arh (autosomal recessive
hypercholesterolemia; Morris and Cooper, 2001; Maurer and
Cooper, 2006). The cellular mechanisms have been investigated
and detailed, that Dab2 is able to recruit LDL receptor into
clathrin-coated pits and facilitate endocytosis (Maurer and
Cooper, 2006; Mulkearns and Cooper, 2012).
Deletion of Dab2 gene in mice only results in a small increase
of serum cholesterol level (Moore et al., 2013), while Arh
mutation significantly elevates serum LDL and cholesterol levels
in mice (Jones et al., 2003, 2007; Harada-Shiba et al., 2004) and
also human (Garcia et al., 2001). However, in the absence of
Arh, the additional loss of Dab2 greatly augments serum LDL
and cholesterol levels to an extent similar to that observed in
LDL receptor null mice (Tao et al., 2016a). The finding leads to
the conclusion that Dab2 does not cooperate but complements
Arh in LDL receptor endocytosis in the clearance of serum LDL
particles. Nevertheless, a surprising finding is that Dab2 is not
expressed in hepatocytes, but rather in the sinusoidal endothelial
cells in liver (Tao et al., 2016a). The study concludes that the
combination of Arh and Dab2 is responsible for the majority
of adaptor functions in LDLR endocytosis and LDLR-mediated
cholesterol homeostasis. In the absence of Arh, Dab2 in liver
endothelial cells regulates the expression of HMG-CoA reductase
and cholesterol synthesis in hepatocytes (Tao et al., 2016a). How
Dab2-mediated endocytosis of LDL in sinusoidal endothelial cells
affects cholesterol synthesis in attached hepatocytes has yet to be
resolved (Tao et al., 2016a).
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ROLES OF DAB2 IN KIDNEY: PROTEIN
RE-UPTAKE
An initial survey indicated that Dab2 is expressed widely in
most tissues and particularly abundantly in the kidney (Fazili
et al., 1999), and indeed kidney was confirmed to be one of the
highest expressing tissues profiled from a large public expression
database (Figure 2), and the expressing cells was found later
to be the kidney epithelial cells lining the proximal convoluted
tubule (Moore et al., 2013). LRP2/Megalin was one of the first
endocytic cargos identified for the Dab2 adaptor (Oleinikov et al.,
2000; Yang et al., 2002a), and megalin/Dab2 mediated protein
re-uptake in the proximal tubule cells is an likely physiological
function of Dab2 in kidney. Indeed, Dab2 null mice have a
mild proteinuria (Morris et al., 2002b; Moore et al., 2013). The
redundant function of Arh with Dab2 may account for the very
mild kidney functional defect in the Dab2 null mice (Nagai et al.,
2003).
ROLES OF DAB2 IN MAMMARY
INVOLUTION
An interest to examine a potential role of Dab2 in mammary
glands was prompted by the findings that Dab2 expression is
lost in breast cancer (Sheng et al., 2000b) and in carcinogen-
induced rodent mammary tumors (Schwahn and Medina, 1998;
Medina, 2002). Among the mouse tissues surveyed, the lactating
mammary gland has relatively high Dab2 expression (Figure 2).
In the general characterization of Dab2 in mice, its expression
was found to be absent or very low in virgin mammary
epithelial cells, but is greatly induced in mammary glands
during pregnancy and lactation (Tao et al., 2014). In primary
cultures of mammary epithelial cells isolated from either virgin
or pregnant mice, Dab2 expression can be induced by estrogen,
progesterone, and prolactin, individually and also synergistically.
The hormonal regulation of Dab2 expression in mammary
epithelial cells is unique, since the expression was not seen to be
significantly altered by sterol hormones in other tissues or cell
types.
Based on its functions in endocytosis, initial speculations
for the roles of Dab2 in mammary glands during pregnancy
and lactation were phenotypes such as cell growth and survival,
nutrient uptake, milk production, and secretion that were
suggested (Chlon et al., 2008). However, despite rigorous
investigation, these phenotypes were not found, and only subtle
differences were observed between control and Dab2-deficient
mice (Tao et al., 2014). The lack of more noticeable differences
in the mammary glands of Dab2 null mice may be due to
the compensation of other endocytic adaptors, such as Numb
and Arh. Indeed, Numb and Arh protein levels are elevated in
Dab2-deficient mammary epithelial cells (Tao et al., 2014).
The most robust phenotype of Dab2 null mammary glands
is a transient delay in mammary involution (Tao et al., 2014).
For mammary morphology, the impact of Dab2 deletion is most
obvious at day 3 of forced involution; however, no permanent
changes in mammary glands of Dab2 null mice are noted.
The rapid cell death and tissue regression during mammary
involution is a tightly controlled process (Furth et al., 1997; Furth,
1999), and TGF-beta signaling is known to play a crucial role
(Bierie et al., 2009). In the studies of primary mammary epithelial
cells in cultures, Dab2 deletion appears to influence Grb2-
mediated TGF-beta Ras/MAPK activation, but does not alter
the phosphorylation and activation of the Smad family proteins,
which is the canonical pathway of TGF-beta signaling (Tao et al.,
2014). Therefore, it was concluded that Dab2 modulates the
non-canonical pathways of TGF-beta by suppressing Ras/MAPK
activation (Mulder, 2000; Moustakas and Heldin, 2005; Lee et al.,
2007; Guo and Wang, 2009; Zhang, 2009; Parvani et al., 2011).
The increased TGF-beta-stimulated Ras/MAPK activation and
subsequent induction of higher expression of survival genes
(Boucher et al., 2000; Balmanno and Cook, 2009) may explain
the prolonged survival of mammary epithelial cells of Dab2-null
mice during involution (Tao et al., 2014). The role of Dab2 in
mammary glands is suggested in that the induction of Dab2
suppresses TGF-beta-induced Erk1/2 activation to allow rapid
cell death in mammary involution.
Despite the high expression and hormonal induction of
Dab2 in mammary glands of pregnant/lactating mice, only
a subtle phenotype (transient delayed mammary involution)
was identified in the mammary tissues of the Dab2 null mice
(Tao et al., 2014). Induction of Dab2 expression likely acts
as a feedback loop for the hormonal induction of mammary
gland expansion during pregnancy and lactation, and the
presence of Dab2 allows efficient cell death and clearance in
mammary involution. From epidemiological studies, pregnancy
and lactation at early age is known to have a small protective effect
against breast cancer (Kelsey and Gammon, 1991). Thus, the
induction of Dab2 expression may contribute to the protection
against breast cancer risk that pregnancy and lactation may offer.
ROLES OF DAB2 IN IMMUNE CELLS
Dab2 cDNA was first cloned from a macrophage cDNA library
(Xu et al., 1995), and macrophages are one of the cell types
with highest Dab2 expressing (Figure 3). Studies of cultured cells
suggested that Dab2 acts in macrophage spreading and adhesion
(Rosenbauer et al., 2002). The functions of Dab2 in macrophages
were suggested to promote inflammation in brain (Jokubaitis
et al., 2013), adipose tissue (Adamson et al., 2016), rat spinal cord
injury (Ahn et al., 2011, 2015), and central nervous system (Moon
et al., 2005).
Dab2 gene deletion was reported to affect regulatory T
cell (Treg) function (Jain et al., 2009). In in vitro assay,
Dab2-restricted knockout of Treg cells failed to suppress the
proliferation of responder T cells. However, mice with Dab2
deletion in Treg cells are healthy in appearance and do not show
phenotypes related to autoimmunity defects even at 1 year of
age, indicating that the Dab2 is dispensable for Treg cells in
maintaining T cell tolerance (Jain et al., 2009). In additional
analysis, it was observed that Dab2-deficient Treg cells failed
to alleviate established colitis, suggesting a role of Dab2 in
regulating lymphocyte infiltration and accumulation in the colon.
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A mechanism was suggested that the Dab2-deficient Treg cells
are poor suppressors in vitro due to a deficiency in gap junctions
for transferring cAMP to effector T cells, because of a role for
Dab2 in endocytic trafficking of connexins, components of the
gap junctions (Jain et al., 2009).
Thus, the functions of Dab2 in immunity, either in
macrophage or Treg cells, are still an outstanding issue that
requires further analyses, especially in challenged conditions.
DAB2 IN TUMOR SUPPRESSION
The link of Dab2 to oncogenesis was first made in a differential
expression screening experiment, in which a short mRNA
fragment was identified as DOC-2 (differentially expressed in
ovarian cancer, known as Dab2 at a later time), and the mRNA
was found lost in ovarian cancer (Mok et al., 1994). Follow
up studies corroborated the loss of Dab2 expression in ovarian
and breast cancer and its cell growth suppressive activity, and
substantiated the proposal for Dab2 as a tumor suppressor (Mok
et al., 1998; Fazili et al., 1999). Another early support was
the identification of Dab2 as a suppressed gene in carcinogen-
induced mammary tumors in rodents (Schwahn and Medina,
1998). Several subsequent reports corroborated loss or a reduced
Dab2 expression in human breast cancer (Sheng et al., 2000b;
Bagadi et al., 2007). To date, Dab2 expression has been reported
to be reduced or lost in many additional cancer types, including
colon (Kleeff et al., 2002), prostate (Tseng et al., 1998), esophageal
(Anupam et al., 2006), nasopharyngeal (Tong et al., 2010), and
head and neck (Hannigan et al., 2010).
A suggestive observation is that the loss of Dab2 expression
occurs in an epithelial layer, and correlates closely with
morphological transformation from a benign monolayer to
malignant multiple layered ovarian cancer (Yang et al., 2002b).
Systematic analysis of a large panel of ovarian carcinomas showed
that loss of Dab2 expression occurs in about 90% of ovarian
cancer, and is an early event in ovarian tumorigenicity (Fazili
et al., 1999).
Earlier analysis of Dab2 tumor predisposable phenotypes was
done using heterozygous knockout mice, which were observed
to have frequent uterine hyperproliferation and atypia, and
increased ovarian epithelial growth and changes (Yang et al.,
2006), though no increased tumor incidence was reported in
the characterization of a Dab2 conditional knockout line (using
Meox2-Cre; Morris et al., 2002b). For another Dab2 conditional
line produced more recently, increases in incidence of tumors
and preneoplastic lesions were noticed (Moore et al., 2013).
The aged Dab2 null mice have higher frequency of tumors
upon dissection, observed mainly in the uterus, ovary, liver,
mammary gland, and colon, similar to the previous report for the
dab2 heterozygous mice (Yang et al., 2006; Moore et al., 2013).
Nevertheless, tumor incidence is relatively low (about 10%) and
likely loss of Dab2 contributes but is not sufficiently to cause
tumorigenesis.
The tumor suppressor functions of Dab2 have been attributed
to its roles in suppressing Ras/MAPK signaling (He et al., 2001;
Zhou and Hsieh, 2001), epithelial organization (Sheng et al.,
2000b; Yang et al., 2002b, 2007), and cell adhesion/migration
(Chetrit et al., 2009; Chao and Kunz, 2009; Chetrit et al., 2009;
Teckchandani et al., 2009; Xie et al., 2015).
ROLES OF DAB2 IN ADIPOCYTE
DIFFERENTIATION
When Sox2-Cre is used to delete Dab2 gene in the cre-lox
conditional knockout mice to bypass the its role in early
embryogenesis (Yang et al., 2002a, 2007), live mice are produced
(Moore et al., 2013). Sox2-Cre is expressed in the inner cell mass
and delete Dab2 gene in a mosaic fashion, and the embryo proper
is essentially depleted of Dab2 allele by E9.5 (Moore et al., 2013).
Dab2 null mice are produced at an expected ratio and the mice
are essentially phenotypically normal in unchallenged conditions
(Moore et al., 2013).
In a high fat and caloric feeding experiment that was to
investigate cholesterol metabolism, an unexpected observation
was that the Dab2 null mice were resistant to high fat diet-
induced weight gain (Tao et al., 2016b). The most prominent
phenotype of Dab2 knockout mice was their striking lean body
composition under a high fat and high caloric diet, although
the weight of the mutant mice was indistinguishable from wild-
type littermates on a regular chow. The remarkable difference
in resistance to high caloric diet-induced weight gain of the
dab2-deleted mice was present only in juvenile but not in
mature mice (Tao et al., 2016b). Restricted Dab2 deletion in
adipose lineage using aP2-Cre supports that this phenotype
is adipocyte cell autonomous, and the adipose lineage Dab2-
deleted (using aP2-Cre) mice have essentially the same levels
of serum glucose, lipids, and other metabolites as wildtypes.
Based on analyses of cell lines and primary stromal mesenchymal
stem cells and cells of the adipose vascular stromal fraction,
the mechanism was determined to be a requirement of Dab2
in adipocyte differentiation (Figure 4; Tao et al., 2016b). In
the pre-adipocytes, Dab2 is required to suppress the activity
of Ras/MAPK, which otherwise phosphorylates the adipogenic
master regulator PPARγ and prevents its adipogenic function
(Tao et al., 2016b).
Interestingly, the Dab2 null mice are nearly indistinguishable
from wildtype mice after birth and when been fed a regular
chow diet, suggesting Dab2 is not required for embryonic
development of adipose tissues, and also Dab2 is not required
for normal function and turnover of adipocytes. Possibly, Dab2
regulates excessive caloric induced pre-adipocyte differentiation,
though the idea still requires further analysis and verification. In
adipose tissues, Dab2 is found to express in pericytes attached
to the vascular structures (Tao et al., 2016b). Whether these
Dab2-positive pericytes are pre-adipocytes that can respond to
excessive caloric signals will need further investigation.
CONCLUSIONS
The phenotypic characterization of the Dab2 null mice has
revealed how endocytosis may impact the physiological functions
in intact animals (Table 1). Dab2 is initially expressed and
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FIGURE 4 | Role of Dab2 in the regulation of adipocyte cell size and number. In mammals, excess food intakes/calories are converted into fat (triacylglycerol)
and is stored in adipocytes. Expansion of adipose tissue is achieved through either enlargement of cell size or multiplication of cell number. In the first phase, the
adipocytes expand in cell size to accommodate the expanding lipid droplet. The second phase of adipose expansion involves the recruitment and differentiation of
precursor cells into new adipocytes. The research results suggest Dab2 is essential for the expansion of adipocyte cell number. The preliminary result suggests that
Dab2 suppresses MAPK and allows the unsuppressed activity of PPARγ to induce adipocyte differentiation. Thus, unsuppressed Ras/MAPK activation in
pre-adipocytes that inhibits the differentiation accounts for the phenotype of resistance to high fat diet-induced weight gain in Dab2 null mice.
mediates endocytosis in the blastocyst stages, and its function
is required for early embryonic development. Although Dab2
is a nonessential gene following completion of development,
the absence of the endocytosis adaptor protein impacts diverse
physiological functions in whole mice, including cholesterol
homeostasis, kidney function, mammary involution, tumor risk,
and high calorie-induced adipose expansion, to name the most
noticeable few (Table 1).
Based on the cellular study of Dab2 functions in the
endocytosis of LRP1 and LRP2 (megalin), integrins, TGF-
beta signaling pathway, Wnt pathway, etc, some additional
phenotypes are expected, but those are either not found or not
significant in whole mice. Redundancy with similar adaptors,
especially Arh and numb that are expressed in the same cell types,
may obscure the physiological impacts and roles of Dab2. Also,
some speculated cellular functions may not be physiological due
to low expression in the tissues and cell types and the phenotypes
observed in cultured cells do not present in the whole animals.
In sum, although Dab2 null mice are largely normal, slight
challenges were able to reveal several physiological changes.
Likely, the phenotypes described in this article are incomplete,
and surely additional Dab2 physiological functions will continue
to be uncovered. So far, the observed physiological functions can
be accounted for by the cellular function of Dab2 in endocytosis:
substrate uptake andmodulation of signaling pathway (especially
Ras/MAPK pathway).
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